Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast-enhanced ultrasound.

Naoki KamachiMasahito NakanoShusuke OkamuraTakashi NiizekiHideki IwamotoShigeo ShimoseTomotake ShironoYu NodaRyoko KuromatsuHironori KogaTakuji Torimura

Published in: Cancer reports (Hoboken, N.J.) (2021)

Early blood flow evaluation by CEUS may be useful in predicting the therapeutic effect of LEN for unresectable advanced HCC.

Keyphrases

blood flow
contrast enhanced ultrasound
locally advanced
squamous cell carcinoma
radiation therapy